LeMaitre Vascular to Present at Upcoming Investor Conferences

LeMaitre Vascular (Nasdaq:LMAT) announced its participation in two upcoming investor conferences in January 2021.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

LeMaitre Vascular (Nasdaq:LMAT) announced its participation in two upcoming investor conferences in January 2021. CFO JJ Pellegrino will present at the 23rd Annual Needham Virtual Growth Conference on January 11, 2021, at 11:30 AM ET, and at the Sidoti Winter 2021 Investor Conference on January 14, 2021, at 10:45 AM ET. The company, which specializes in devices for treating peripheral vascular disease, aims to inform and engage investors about its market position and growth strategies.

Argus Session date unavailable

+1.80% session move Open Argus

Details

News Market Reaction – LMAT

The recorded move for LMAT in the trading session of this news was +1.80%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

12/29/2020 - 06:03 PM

BURLINGTON, Mass., Dec. 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in January.

JJ Pellegrino, Chief Financial Officer, is scheduled to present at the 23rd Annual Needham Virtual Growth Conference on Monday, January 11, 2021, at 11:30 AM ET.

JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Sidoti Winter 2021 Investor Conference on Thursday, January 14, 2021, at 10:45 AM ET.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What conferences is LeMaitre Vascular participating in January 2021?

LeMaitre Vascular is participating in the 23rd Annual Needham Virtual Growth Conference on January 11, 2021, and the Sidoti Winter 2021 Investor Conference on January 14, 2021.

Who is presenting for LeMaitre Vascular at these conferences?

CFO JJ Pellegrino will present for LeMaitre Vascular at both conferences.

What is the purpose of LeMaitre Vascular's participation in these investor conferences?

The participation aims to engage investors and provide insights into the company's market position and growth strategies.

What is LeMaitre Vascular known for?

LeMaitre Vascular is known for providing devices, implants, and services for the treatment of peripheral vascular disease.

How many people are affected by peripheral vascular disease worldwide?

Peripheral vascular disease affects more than 200 million people worldwide.

Keep reading

Trending in the feed

RDW

Sophia Space and Redwire Team Up to Advance Orbital Data Center Infrastructure Open the live feed